Study Links Risk of Vision Loss to Weight Loss Drug Semaglutide, Experts Call for Monitoring

Study Links Risk of Vision Loss to Weight Loss Drug Semaglutide, Experts Call for Monitoring

The study found that there is a potential risk of the development of non-arteritic ischemic optic neuropathy, a potentially debilitating condition caused by insufficient blood flow to the optic nerve that could lead to sudden vision loss